Nanoparticle Characterisation Company's Angel Investor Round Oversubscribed

NanoSight Limited, the nanoparticle characterisation company, announces the completion of an angel investor round that increases its shareholder base and complements previous investments by Venture Capital companies, including NESTA, Strathdon and South West Ventures. The angel investment came from members of the SWAIN and OEI Investment Networks.

John Knowles, Chairman of NanoSight, comments, “The investment round was oversubscribed, which is very encouraging for the company, and brings on board a group of investors with experience in growing high technology companies. We aim to use the funds to support the growth of our worldwide distributor network and to increase the functionality of the NANOSIGHT LM20 and LM10 systems.

“We are working with our customers in a number of exciting areas of nanoparticle research. It is vital that we support our users in their applications as they discover the potential of our unique technology and our ability to respond rapidly with major software and hardware enhancements.”

The NANOSIGHT LM10 and LM20 systems deliver higher resolution particle size distribution profiles than other more time-consuming and expensive methods with minimal sample pre-treatment and only dilution with a suitable solvent to an acceptable concentration range. The NTA software package measures the speed and thus hydrodynamic size of individual particles in suspension and avoids the complex correlation mathematics required in assessing the intensity signal inherent in light scattering techniques. The software enables real-time dynamic nano-particle visualisation from which independent quantitative estimation of particle size and size distribution can be immediately obtained.

“Both systems and the associated software have been developed with our customers to support their growing research needs across the chemical and biotechnology industries,” says Jeremy Warren, CEO of NanoSight. “For example, the LM20 system enables non-microscope users to quickly and accurately analyse nanoparticles in suspension and serves as an important complement to light scattering techniques, such as Dynamic Light Scattering (DLS).”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.